SMSbiotech
SMSbiotech is a San Diego-based biotech company focused on advancing regenerative medicine through the discovery and application of a novel human stem cell technology. Their mission is to democratize the application of adult stem cell technologies for human health, aiming to provide safe, affordable, and ethically grounded regenerative medicine solutions.
SMSbiotech
1825 Diamond St Ste 101, San Marcos, CA 92078
What We Do
Small Mobile Stem Cells (SMS)
A novel, patented approach that produces unique human allogeneic adult Small Mobile Stem (SMS) cells, aimed at addressing chronic and age-related diseases.
Biologics
Application Area
Services
Key People
Abdulkader Rahmo, PhD
Co-Founder, President, CSO
Harry Friedman
Chief Financial Officer
Roger Schechter, MD
Clinical Research Director
News & Updates
SMSbiotech has received a new European patent for compositions and methods for using Small Mobile Stem Cells, issued on September 4, 2024.
Issuance of Europe Letters Patent No. 3,436,035 for compositions and methods for using Small Mobile Stem Cells, issued on September 4, 2024.